🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Vaccine

Addressing Unfunded Vaccines Through a Co-payment Mechanism in Pharmacies NCT06489964NA2 sites📍 Halifax📍 Kitchener Canadian Immunization Research Network · Tests: Co-payment Model - Step 1, Co-payment Model - Step 2, Co-payment Model - Step 3, Co-payment Model - Step 4 Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children NCT05758532Phase 41 site📍 Geneva Laure Pittet, MD-PhD · Tests: Measles-Mumps-Rubella vaccine (MMR) DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau NCT07142278Phase 11 site📍 Miami Lakes Nuravax, Inc. · Tests: DUVAX 200 µg, DUVAX 400 µg, Placebo (Adjuvant only) Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms NCT06026774Phase 11 site📍 Hangzhou Sir Run Run Shaw Hospital · Tests: iNeo-Vac-R01 in combination with standard adjuvant therapy A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL. NCT03219450Phase 11 site📍 Boston Dana-Farber Cancer Institute · Tests: NeoVax, Cyclophosphamide, Pembrolizumab A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age NCT07406360Phase 317 sites📍 Birmingham📍 Walnut Creek📍 Miami GlaxoSmithKline · Tests: MMRVNS, MMRV Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population NCT05580458Phase 1, Phase 21 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Shingrix Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer NCT07539155Phase 1, Phase 21 site📍 Little Rock University of Arkansas · Tests: Intratumoral MMR Injection Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates NCT02471378n/a1 site📍 Bamako National Institute of Allergy and Infectious Diseases (NIAI… rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG NCT04943848Phase 13 sites📍 Orange📍 Chicago📍 Boston Ann & Robert H Lurie Children's Hospital of Chicago · Tests: rHSC-DIPGVax, Balstilimab, Zalifrelimab An Experimental Medicine Multicenter Trial to Evaluate the Safety and Immunogenicity of Experimental Versus Authorized SARS-CoV-2 Vaccine Candidates as a Booster Dose in Healthy Participants Previously Vaccinated With Authorized mRNA SARS-CoV-2 Vaccines. NCT07605520EARLY Phase 13 sites📍 Créteil📍 Paris📍 Lausanne ANRS, Emerging Infectious Diseases · Tests: CD40.RBDv vaccine adjuvanted with Hiltonol®, CD40.Pan.CoV vaccine adjuvanted with Hiltonol®, Comirnaty® vaccine, Nuvaxo… An Exploratory Study of Individualized Neo-antigen mRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment NCT06497010EARLY Phase 11 site📍 Guiyang The Affiliated Hospital Of Guizhou Medical University · Tests: Biological: PD-1, Biological: InnoPCV Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer NCT06631092Phase 1, Phase 22 sites📍 Erlangen📍 Heidelberg NEC Bio B.V · Tests: Oral DNA Vaccine Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2 NCT06848309n/a1 site📍 St Louis Washington University School of Medicine · Tests: Bronchoscopy Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults NCT06863142Phase 11 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… · Tests: VRC-FLUMOS0116-00-VP, ALFQ Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta? NCT05923970n/a1 site📍 Edmonton University of Alberta · Tests: Serology for antibody levels - Baseline, Serology to assess cell mediated immune (CMI) response - Baseline, Serology fo… National Bacterial Meningitis Study in Children and Newborns NCT04664569n/a1 site📍 Créteil Association Clinique Thérapeutique Infantile du val de Marne To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years NCT06756269Phase 21 site📍 Nanning Shanghai Bovax Biotechnology Co., Ltd. · Tests: Medium dose for 15-HPV vaccine, High dose for 15-HPV vaccine, Placebo, 9-HPV vaccine CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults NCT06305910Phase 11 site📍 Minneapolis OX2 Therapeutics · Tests: Treatment with CD200AR-L Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial NCT05183854Phase 21 site📍 Salt Lake City University of Utah · Tests: Pneumococcal 20-valent Conjugate Vaccine, Pneumococcal Polyvalent Vaccine Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma. NCT07077616EARLY Phase 11 site📍 Thessaloniki Biogenea Pharmaceuticals Ltd. · Tests: Biological: personalized vaccine Based on genetic and transcriptional sequencing information, personalized peptide vacc… Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors NCT07146672Phase 1, Phase 21 site📍 Shanghai Shanghai Cell Therapy Group Co.,Ltd · Tests: Super DC Vaccine A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV NCT05495906Phase 410 sites📍 Surrey📍 Vancouver📍 Winnipeg University of British Columbia · Tests: Nonavalent HPV vaccine NWRD06 DNA Plasmid for HCC After Curative Resection. NCT07324304Phase 26 sites📍 Beijing📍 Beijing📍 Beijing Newish Technology (Beijing) Co., Ltd. · Tests: NWRD06 administered by electroporation A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults NCT07628049Phase 1, Phase 25 sites📍 Stockbridge📍 Lenexa📍 Seattle GlaxoSmithKline · Tests: RSV/hMPV_V low dose vaccine, RSV/hMPV_V medium dose vaccine, RSV/hMPV_V high dose vaccine, RSV/hMPV_W low dose vaccine,… Safety and Efficacy of wSp Vaccine in Young Children NCT07216430Phase 27 sites📍 Pittsford📍 Rochester📍 Rochester Serum Life Science Europe GmbH · Tests: wSp vaccine, Saline (0.9% NaCl) A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant NCT04006808Phase 1, Phase 231 sites📍 Brussels📍 Ghent📍 Leuven GlaxoSmithKline · Tests: PED-HZ/su Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer NCT06441110Phase 31 site📍 Fuzhou Fujian Medical University Union Hospital · Tests: Tislelizumab in Combination with Bacillus Calmette-Guérin Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer NCT06782932Phase 1, Phase 21 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: AGEN2373, Balstilimab, Cyclophosphamide, GVAX, AGEN2373 (RP2D) A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age. NCT07555392Phase 2, Phase 310 sites📍 Guwahati📍 Patna📍 Raipur Bharat Biotech International Limited · Tests: BBV87 Chikungunya vaccine, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy